Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Sanofi Wins Second Test Trial in Taxotere Cancer Drug Litigation

Nov. 22, 2021, 9:31 PM

Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. were again cleared of liability in litigation linking the breast cancer drug Taxotere to permanent hair loss, according to a judgment entered Monday in a Louisiana federal court.

Elizabeth Kahn alleged the drugmaker didn’t adequately warn that hair loss, a common side effect of chemotherapy, could be permanent.

Her suit was the second test trial and the second defense win in a multidistrict proceeding in the U.S. District Court for the Eastern District of Louisiana by women alleging they would have chosen a less toxic drug had they known the likelihood of ...